Genzyme Corporation
Genzyme confident of restarting virus-hit Allston plant by August
26 June 2009
Genzyme Corp shuts key facility to clean plant contamination
17 June 2009
Bayer HealthCare and Genzyme finalise strategic alliance agreement
02 June 2009
Bayer sells 3 cancer drugs to Genzyme for $650 million
01 April 2009
Genzyme and Isis announce strategic alliance including exclusive worldwide license of Mipomersen
08 January 2008
Genzyme announces FDA approval of Thyrogen for thyroid cancer ablation
18 December 2007
Genzyme nets 22 per cent stake in Bioenvision
14 July 2007
Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market
11 August 2004
 search domain-b
  go